PremiumThe FlyInspireMD announces inducement grants under Nasdaq listing rule InspireMD files $200M mixed securities shelf InspireMD Inc. Reports 2024 Financial Results and Strategic Progress PremiumThe FlyInspireMD participates in a conference call with Lake Street InspireMD, NAMSA partner on CGUARDIANS II trial of CGuard Prime InspireMD announces inducement grants under Nasdaq listing rule PremiumCompany AnnouncementsInspireMD Advances CGuard Prime with New Clinical Trial InspireMD announces first patient enrolled in CGUARDIANS II study InspireMD Strengthens Leadership with Scott R. Ward Appointment